BrightHeart key facts
as of Oct 2026- Developer of an artificial intelligence-driven ultrasound screening software designed to detect congenital heart defects in fetuses.
- BrightHeart is valued at approximately $234.8M as of Oct 2026 (last reported valuation).
- It has raised $15.1M; the latest was Later Stage VC ($12.9M) in Jan 2026.
- Notable investors include Sofinnova Partners, GO Capital, Odyssee Venture, Lift Value, John Gridley — 9 tracked in total.
- Status: Privately Held (backing).
BrightHeart's last reported valuation, Jan 2026. Nothing priced has surfaced since.
- ·Watch BrightHeart: the Monday email on marks, rounds and moves
BrightHeart funding rounds
No funding rounds for BrightHeart are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
BrightHeart valuation
BrightHeart's last reported valuation was $235 million in Jan 2026. No priced round, secondary trade or fund mark has surfaced since.
BrightHeart investors
9 investors are on record for BrightHeart, including Sofinnova Partners, GO Capital, Odyssee Venture and Lift Value.
About BrightHeart
Developer of an artificial intelligence-driven ultrasound screening software designed to detect congenital heart defects in fetuses. The company's software provides real-time guidance by consistently performing prenatal ultrasounds and informing decisions to optimize pregnancy and delivery management, enabling clinicians to access support for prenatal identification of congenital heart defects.
- Sector
- Healthcare
- HQ
- Paris, France
- Founded
- 2020
- Employees
- 10
- Website
- brightheart.ai/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.